Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Developing drugs without animal testing

Dear Sir or Madam,

Before a drug can enter the market, it needs to undergo animal testing, among other things. This does not only raise ethical questions, but is also costly. An alternative has been researched for some years now: The body-on-a-chip houses different human cells and is thus supposed to show the effects of drugs on the body – without animal testing. Learn more in our current video.

Have a nice week,

Timo Roth
Editorial team MEDICA-tradefair.com

Table of Contents

Topic of the Month: Hospital cybersecurity
Video: Multi-organ chips
Newsletter Service
RSS Service
Newsletter Archive

Cybersecurity in the hospital: securely networked

Topic of the Month

Image: A male and a female physician look at a tablet together; Copyright: panthermedia.net/Wavebreakmedia Ltd.
Digitalization and networking are supposed to serve the health care system well: In times of staff shortages and demographic change, they are able to support the exchange of patient data and the management of chronic diseases as well as to improve the workflow. But it is still often ignored that both individual devices and complete networks can become lucrative targets for cybercrimes like data theft.
Read more in our Topic of the Month:
Cybersecurity in the hospital: securely networked
To top

Laboratory Equipment, Diagnostica, Research & Technology

Tissue Engineering: producing tissue and organs through lithography

The production of artificial organs is a hot research topic. In the near future, artificial organs will compensate for the lack of organ donations and replace animal experiments. Although there are already promising experiments with 3D printers that use a "bio-ink" containing living cells, a functional organ has never been created in this way.
read more
To top

Research & Technology, Information and Communication Technology

mHealth: AI to enhance cognitive performance

Researchers have shown that AI could potentially be used to customise training regimens for individuals to personalise learning and improve cognitive performance. Using performance data from a given person, CURATE.AI creates an individualised profile that enables cognitive training to be tailored to the individual's learning habits and competencies so as to enhance training effectiveness.
read more
To top

Laboratory Equipment, Diagnostica, Research & Technology

Blood test: How effective is stem cell transplantation?

University of Maryland School of Medicine study shows the potential of transplanted stem cell secretions as a liquid biopsy.
read more
To top

Research & Technology, Information and Communication Technology

Wearables: World's first wearable kidney

An artificial portable kidney that patients who have suffered renal failure could wear is to be created by a research team at the University of Saskatchewan with federal funding.
read more
To top

Multi-organ chips: Drug research without animal testing at vasQlab

Video

Image: Preview image of the video
New active substances that are suitable for drugs are initially tested in animal experiments. However, the results cannot always be transferred to the human organism. At the Karlsruhe Institute of Technology, Prof. Ute Schepers from vasQlab explains how active substances can be tested in human tissue without endangering human health.
Watch the video here!
Multi-organ chips: Drug research without animal testing at vasQlab
More videos in our MediaCenter
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Wolfram N. Diener, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Messe Düsseldorf GmbH processes your personal data. The data protection regulations of Messe Düsseldorf GmbH hold information in closer detail to this subject and are available under www.messe-duesseldorf.de/privacy. You may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, VG-R, PF 101006, 40001 Düsseldorf, Germany.

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.